Axon CRO sells 1,242 shares at $500 each

Axon Enterprise, Inc. chief revenue officer Cameron Brooks reported an open-market sale of Common Stock.

Rhea-AI Filing Summary

Axon Enterprise, Inc. chief revenue officer Cameron Brooks reported an open-market sale of Common Stock. On June 4, 2026, he sold 1,242 shares at a price of $500.00 per share. Following this transaction, he directly holds 49,709.933 shares of Axon Common Stock.

According to a footnote, this sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025, indicating the trade was scheduled in advance rather than timed discretionarily.

Insider Trade Summary 10b5-1

Net Seller: 1,242 shares

Net Sell 1 txn

Insider Brooks Cameron

Role CHIEF REVENUE OFFICER

Sold 1,242 shs ($621K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,242	$500.00	$621K

Holdings After Transaction: Common Stock — 49,709.933 shares (Direct)

Footnotes (1)

1. F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025.

Key Figures

Shares sold: 1,242 shares Sale price: $500.00 per share Shares held after transaction: 49,709.933 shares +3 more

6 metrics

Shares sold 1,242 shares Common Stock sold on June 4, 2026

Sale price $500.00 per share Open-market sale on June 4, 2026

Shares held after transaction 49,709.933 shares Direct ownership following June 4, 2026 sale

Net buy/sell shares -1,242 shares Net activity in this Form 4

Transaction type Open-market sale (Code S) Non-derivative Common Stock

Trading plan adoption date December 8, 2025 Rule 10b5-1 trading plan referenced in footnote

Key Terms

Rule 10b5-1 trading plan, open-market sale, Common Stock, Form 4, +1 more

5 terms

Rule 10b5-1 trading plan financial

"effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

transaction code S regulatory

""transaction_code": "S""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Axon (AXON) report for Cameron Brooks?

Axon reported that chief revenue officer Cameron Brooks sold 1,242 shares of Common Stock. The transaction occurred on June 4, 2026, and was an open-market sale at $500.00 per share, as disclosed in a Form 4 insider trading report.

At what price did Cameron Brooks sell Axon (AXON) shares?

Cameron Brooks sold Axon Common Stock at $500.00 per share. The Form 4 identifies this as the transaction price for 1,242 shares sold in an open-market transaction dated June 4, 2026, under his disclosed trading activity.

How many Axon (AXON) shares does Cameron Brooks hold after this sale?

After the reported sale, Cameron Brooks holds 49,709.933 shares of Axon Common Stock. This post-transaction balance reflects his remaining direct ownership following the June 4, 2026 open-market disposition of 1,242 shares reported on Form 4.

Was the Axon (AXON) insider sale by Cameron Brooks under a 10b5-1 plan?

Yes. A footnote states the transactions were effected under a Rule 10b5-1 trading plan adopted by Cameron Brooks on December 8, 2025. Such plans are pre-arranged trading programs designed to systematically execute trades over time.

What role does Cameron Brooks hold at Axon (AXON) in this Form 4?

In the Form 4, Cameron Brooks is identified as Axon’s chief revenue officer. The filing classifies him as an officer, not a director or 10% owner, and discloses his direct ownership of Common Stock before and after the June 4, 2026 sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/08/2026 - 04:56 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brooks Cameron

(Last) (First) (Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE ARIZONA 85255

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF REVENUE OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		S(1)		1,242	D	$500	49,709.933	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025.

Remarks:

	/s/ Cameron Brooks by Isaiah Fields, Attorney-in-Fact	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)